4/19/2024  3:32:26 PM Chg. -0.0410 Volume Bid9:59:38 PM Ask9:59:38 PM Market Capitalization Dividend Y. P/E Ratio
8.0080EUR -0.51% 0
Turnover: 0.0000
-Bid Size: - -Ask Size: - 2.98 bill.EUR - -

Business description

Bausch Health Companies Inc. is a global company whose mission is to improve people's lives with health care products. Bausch develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.
 

Management board & Supervisory board

CEO
Thomas J. Appio
Management board
Tom Vadaketh, Seana Carson, Mirza Dautbegovic, Kathleen Fitzpatrick, Jeff Hartness, Cees Heiman, Graham Jackson, Jiny Kim, Donald Pearl, Josh Coyle, Nicola Kayel, Dr. Tage Ramakrishna, M.D., Tom Stern, Fernando Zarate
Supervisory board
John A. Paulson, Thomas J. Appio, Brett M. Icahn, Sarah B. Kavanagh, Steven D. Miller, Dr. Richard Mulligan, Robert N. Power, Russel C. Robertson, Thomas W. Ross, Sr., Amy B. Wechsler, M.D.
 

Company data

Name: Bausch Health Companies Inc.
Address: 2150 St. Elzéar Blvd. West,Laval, Quebec H7L 4A8, Canada
Phone: +1(800) 361-1448
Fax: -
E-mail: -
Internet: https://www.bauschhealth.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: -
IPO date: -

Investor relations

Name: Arthur Shannon
IR phone: +1-877-281-6642
IR Fax: -
IR e-mail: ir@bauschhealth.com

Company calendar

CW 18 | 5/2/2024 Interim Report 1st Quarter/3 Months
 

Main Shareholders

Others
 
52.85%
Icahn Carl C
 
9.62%
Paulson & Company, Inc.
 
7.32%
Goldentree Asset Management LP
 
5.56%
Franklin Resources, Inc.
 
4.59%
Bank of Montreal
 
4.17%
National Bank of Canada
 
3.65%
Hudson Bay Capital Management Lp
 
3.19%
Nomura Holdings Inc.
 
3.13%
Others
 
5.92%